CircATIC accelerated the proliferation, migration, invasion, and glycolysis and suppressed the apoptosis of MM cells through mediating miR-324-5p/HGF signaling.
CircATIC Contributes to Multiple Myeloma Progression via miR-324-5p-Dependent Regulation of HGF.